alexa Inhibition Of Glycosylation As An Index Of Activity In Plants With Antidiabetic Potentials | 13970
ISSN: 2167-0501

Biochemistry & Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

International Conference on Pharmacognosy, Phytochemistry & Natural Products

Olabiyi A. S, Nkemehule F. E, Odukoya O. A, Samuel T. A and Ogbonnia S. O
Accepted Abstracts: Biochem & Pharmacol
DOI: 10.4172/2167-0501.S1.004
Abstract
The non-enzymatic glycosylation of haemoglobin has been established and shown to be significantly increased in diabetes. Advanced glycosylation end-products (AGEs) promote the development and progression of diabetic complications. Twenty plants were selected from Lagos metropolis in Nigeria for the study. The inhibitory properties of the ethanolic extracts of each plant on glycosylation of haemoglobin as an index of antidiabetic property were investigated using quercetin as Standard. The ethanolic (96%) extracts of the plants were phytochemically analyzed for the presence of phenolic compounds and the total phenolic content of the plants was measured by Folin-Ciocalteu's reagent using gallic acid as a standard. Lophira alata was found to contain the highest amount of phenols with a concentration of 0.515 mg/ml and Citrullus lanatus had the lowest concentration of 0.007 mg/ml. Five plants showed a higher percentage inhibition of glycosylation than quercetin which showed a percentage inhibition of 10.155%. They are Alstonia congensis, Vernonia amygdalina, Alstonia boonei, Sarcocephalus latifolius, Azadirachta indica and Gongronema latifolium with percentage inhibition of 24.799%, 20.310%, 16.429%, 14.036%, 13.441% and 11.953% respectively. From the study, fifteen out of the twenty plants analyzed inhibited the binding of glucose to haemoglobin and thus may be used as adjuncts in antidiabetic therapy.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7